GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Additional Paid-In Capital

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co Additional Paid-In Capital?


China Resources Boya Bio-pharmaceutical Group Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥4,059 Mil) but then stayed the same from Dec. 2024 (¥4,059 Mil) to Mar. 2025 (¥0 Mil).

China Resources Boya Bio-pharmaceutical Group Co's annual additional paid-in capital stayed the same from Dec. 2022 (¥4,059 Mil) to Dec. 2023 (¥4,059 Mil) and stayed the same from Dec. 2023 (¥4,059 Mil) to Dec. 2024 (¥4,059 Mil).


China Resources Boya Bio-pharmaceutical Group Co Additional Paid-In Capital Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co Additional Paid-In Capital Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,940.53 4,251.73 4,059.16 4,059.16 4,059.16

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4,059.16 - 4,059.16 -

China Resources Boya Bio-pharmaceutical Group Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

China Resources Boya Bio-pharmaceutical Group Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Boya Bio-pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000
China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.
Executives
Liang Xiao Ming Directors, executives
Li Shou Sun Executives
Zhang Shi Fang Executives
Tu Yan Shi Directors, executives
Chen Bing Executives
Liao Xin Xi Directors, executives
Fan Yi Qin Secretary, Director
Jiang Guo Liang Supervisors
Xu Jian Xin Director
Duan Hong Zhuan Executives
Chen Hai Yan Executives
Hong Da Cheng Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines